No abstract available
MeSH terms
-
COVID-19*
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use*
-
Lymphopenia / epidemiology
-
Lymphopenia / etiology
-
Multiple Sclerosis / complications*
-
Multiple Sclerosis / drug therapy*
-
Pandemics*
-
Risk